TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes

In this episode, Giorgio Raimondi joins Monica Westley to discuss his research at Johns Hopkins University in the Vascularized and Composite Allotransplantation Laboratory. Dr. Raimondi provides insights to his recently published work titled: "Multiphase Assembly of Small Molecule Microcrystalline Peptide Hydrogel Allows Immunomodulatory Combination Therapy for Long‐Term Heart Transplant Survival....

In this episode, Dan Abebayehu joins Monica Westley to discuss his research in the matrix biology and engineering lab at University of Virginia. His work focuses on examining the role innate immunity plays in initiating fibrosis. Dr. Abebayehu- "Fibrosis emerges across multiple diseases and is often times one of the key obstacles to developing better therapies."

In this episode, Bart Roep joins Monica Westley to discuss the current and future scientific work in the field of type 1 diabetes. Dr. Roep is the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and the founding chair of the Department of Diabetes Immunology  within the  Diabetes & Metabolism Research Institute at City of Hope. He serves as project director for The Wanek Family Project fo...

In this episode, Jeffrey Millman joins Monica Westley to discuss his research. The major focus of the Millman laboratory is the in vitro production and study of pancreatic insulin-producing β cells from human pluripotent stem cells for use in cellular replacement therapy and drug screening.   Dr. Millman- "The field right now is very hot and exciting! With the development and discovery of how to m...

In this episode, Paul-Peter Tak joins Monica Westley to discuss his innovative ideas within the type 1 diabetes space and how immunology can play a role in helping find a cure for T1D. Paul-Peter is an immunologist, academic, and venture partner who has specialized in the fields of rheumatology and immunology.  Paul-Peter Tak- "I think the future is clearly in looking at type 1 diabetes in a diffe...

In this episode, Izortze Santin joins Monica Westley to discuss her research in the type 1 diabetes space. Dr. Gomez is an associate professor at University of the Basque Country and a researcher at BioCruces Health Research Institute.

In this episode, Ali Cinar joins Monica Westley to discuss his research and how he became interested in studying type 1 diabetes. Professor Cinar's research activities are concentrated in three areas: complex adaptive agent-based systems, modeling, simulation and control of biomedical systems, and supervision of manufacturing process operations. 

In this episode, Giovanni Amabile joins Monica Westley to discuss the future of Enthera. Enthera is a biotech company building a pipeline of first-in-class biologics for several autoimmune conditions, with a focus in type 1 diabetes and inflammatory bowel disease.  

In this episode, Jennifer joins Nicole Phillips to discuss her research at UCSF in the Bluestone Lab and Anderson Lab. Jennifer's research focuses on understanding mechanisms regulating T-cell activation and studying an immunosuppressive population of T cells known as Tregs.

In this episode, Rebecca Vaught joins Monica Westley to discuss her work at Van Heron Labs and its' potential intersection with type 1 diabetes. Van Heron Labs created a novel pipeline that uses genetic analysis to design a customized procedure for optimizing metabolism for a particular organism or cell, maximizing growth and product output.

In this episode, Zoe Quandt joins Nicole Phillips to discuss her research in the Bluestone Lab and Anderson Lab at UCSF. Zoe's research focuses on endocrine immune related adverse events following cancer immunotherapy. 

In this episode, Jonny White joins Scott Phillips to discuss life with Type 1 Diabetes. Jonny is a media psychologist who has type 1 diabetes. He has been very influential and active in the T1D world since he was 15. 

In this episode, Lane Desborough joins Sajeev Saluja to discuss finessing blood sugar monitoring. Lane was the cheif engineer for insulin delivery at Medtronic and chief engineer at Bigfoot Biomedical. He is now pursuing a new idea in automated insulin delivery that is currently in stealth mode.

In this episode, Nayara Leite joins Nicole Phillips to discuss her research in The Melton Lab at Harvard University. Nayara's research focuses on using induced pluripotent stem cells for type 1 diabetes in vitro modeling and immunoprotection of beta cells.